Millennium Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Millennium Management’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,565	Closed	-$190K	–	7811
2021 Q4	$190K	Sell	1,565 -11,080	-88%	-$1.87M	﹤0.01%	5941
2021 Q3	$1.78M	Buy	+12,645	New	+$2.51M	﹤0.01%	4059

Other funds holding EVLO

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Millennium Management's EVLO Position: Q4 2023 in Review

Millennium Management sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2023, closing a stake of 38,093 shares — an estimated $149K sold.

Millennium Management first reported a position in EVLO in Q1 2020 and held it in 14 quarters. The position peaked at $1.33M in Q1 2021. 2 funds tracked by Wall St. Rank hold EVLO as of Q4 2023.

Millennium Management reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Millennium Management sold 38,093 Evelo Biosciences, Inc. Common Stock shares in Q4 2023, an estimated $149K.
Millennium Management first reported a position in Evelo Biosciences, Inc. Common Stock in Q1 2020 and held it in 14 quarters.
Millennium Management's Evelo Biosciences, Inc. Common Stock position peaked at $1.33M in Q1 2021.
2 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.